| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | UNI HEALTH (02211): PROVISIONAL ALLOTMENT LETTER | - | HKEx | ||
| Fr | UNI HEALTH (02211): PROPOSED RIGHTS ISSUE ON THE BASIS OF FOUR (4) RIGHTS SHARES FOR EVERY ONE (1) ADJUSTED SHARE HELD ON THE RECORD DATE ON A NON-UNDERWRITTEN ... | 1 | HKEx | ||
| UNIVERSAL HEALTH INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
| Fr | UNI HEALTH FY Loss Narrows to RMB20.429 million | 4 | AASTOCKS | ||
| Mi | UNI HEALTH (02211): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2026 | 3 | HKEx | ||
| 23.09. | UNI HEALTH (02211): EFFECTIVE DATE OF CAPITAL REORGANISATION | 2 | HKEx | ||
| 21.09. | UNI HEALTH (02211): NOTICE OF BOARD MEETING | 1 | HKEx | ||
| 15.09. | UNI HEALTH (02211): POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 15 SEPTEMBER 2026 | - | HKEx | ||
| 07.09. | UNI HEALTH (02211): REVISED FORM OF PROXY FOR USE AT EXTRAORDINARY GENERAL MEETING | 2 | HKEx | ||
| 27.08. | UNI HEALTH (02211): FORM OF PROXY FOR USE AT EXTRAORDINARY GENERAL MEETING | 1 | HKEx | ||
| 27.08. | UNI HEALTH (02211): NOTICE OF EGM | 1 | HKEx | ||
| 27.08. | UNI HEALTH (02211): PROPOSED CAPITAL REORGANISATION; PROPOSED RIGHTS ISSUE ON THE BASIS OF FOUR (4) RIGHTS SHARES FOR EVERY ONE (1) ADJUSTED SHARE HELD ... | 1 | HKEx | ||
| 31.07. | UNI HEALTH (02211): DELAY IN DESPATCH OF CIRCULAR AND REVISED TIMETABLE IN RELATION TO PROPOSED CAPITAL REORGANISATION AND RIGHTS ISSUE | 1 | HKEx | ||
| 17.07. | UNI HEALTH (02211): (I) PROPOSED CAPITAL REORGANISATION; AND (II) PROPOSED RIGHTS ISSUE ON THE BASIS OF FOUR (4) RIGHTS SHARES FOR EVERY ONE (1) ADJUSTED ... | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 44,940 | -1,01 % | 90 Milliarden US-Dollar bis 2030: Wie Bayer, Mesoblast und NurExone regenerative Medizin unterschiedlich entwickeln | ||
| AURORA CANNABIS | 3,518 | +0,86 % | Aurora Cannabis: Übernahmekampf vor der Wende? | ||
| MPH HEALTH CARE | 27,700 | +0,36 % | MPH Health Care: 5-Euro-Dividende - das wird übersehen | ||
| GREEN THUMB INDUSTRIES | 5,880 | -0,51 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| MERCK KGAA | 136,90 | +1,82 % | Merck Aktie | Wichtige Durchschnittslinien durchbrochen | Analyse | ||
| NOVO NORDISK | 33,210 | -0,48 % | Novo Nordisk gerät trotz GLP-1 unter Druck - warum Eli Lilly und Co. schon Milliarden in neue Plattformen investieren | ||
| ETON PHARMACEUTICALS | 55,42 | 0,00 % | Eton Pharmaceuticals, Inc. - 8-K, Current Report | ||
| SANOFI | 71,08 | -0,03 % | Laufende Fusionskontrollverfahren: Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald) | Datum der Anmeldung:24.09.2026Aktenzeichen:B3-102/26Unternehmen:Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald)Produktmärkte:Arzneimittel... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 13,685 | -0,04 % | Generate Biomedicines, Inc.: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer | Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trials First patient treated in new clinical... ► Artikel lesen | |
| SEAPORT THERAPEUTICS | 18,420 | 0,00 % | Seaport Therapeutics Prices Upsized IPO Of 14.16 Mln Shares At $18 Each | WASHINGTON (dpa-AFX) - Seaport Therapeutics, Inc. (SPTX) said it has priced its upsized initial public offering of 14.16 shares at $18 per share, at the top of the target range. The company... ► Artikel lesen | |
| PFIZER | 24,735 | +0,18 % | AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot | ||
| LB PHARMACEUTICALS | 37,080 | +0,24 % | Needham initiates LB Pharmaceuticals stock with buy rating | ||
| ELI LILLY | 1.019,20 | +0,33 % | Eli Lilly (LLY) and AbbVie (ABBV) Are Expanding Their Pipelines. Their Valuations Tell Two Different Stories | ||
| BIOHAVEN | 12,870 | 0,00 % | Biohaven Ltd.: Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the EORTC-NCI-AACR Symposium 2026 | Oral presentation selected: Phase 1 findings from the ongoing BHV1530-101 study will be featured in an oral presentation at the 38th EORTC-NCI-AACR Symposium on... ► Artikel lesen | |
| SCHOTT PHARMA | 24,550 | +0,82 % | Aktien Frankfurt: Dax macht Verluste wett - Ölpreis und Anleiherenditen im Fokus | FRANKFURT (dpa-AFX) - Der deutsche Aktienmarkt hat sich am Dienstagnachmittag von seinen Anfangsverlusten vollständig erholt. Eine leichte Entspannung bei den Ölpreisen und bei den Anleiherenditen... ► Artikel lesen |